NC-stat® DPNCheck® Overview
Watch the NC-stat DPNCheck Overview

For questions about obtaining DPNCheck, please call NeuroMetrix Customer Service at 1-888-786-7287 or to email, click here.

References:

  1. Lee, et al. Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. PLoS One. 2014;9.
  2. Perkins, et al. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care. 2006;29.
  3. Perkins, et al. Multi-site testing with a point-of-care nerve conduction device can be used in an algorithm to diagnose diabetic sensorimotor polyneuropathy. Diabetes Care. 2008;31.
  4. Kong, et al. Utilization of nerve conduction studies for the diagnosis of polyneuropathy in patients with diabetes: a retrospective analysis of a large patient series. J Diabetes Sci Technol. 2008;2.
  5. Pambianco, et al. The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: A comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort. Diabetes Res Clin Pract. 2011;92.
  6. Pambianco, et al. Risk factor associations with clinical distal symmetrical polyneuropathy and various neuropathy screening instruments and protocols in type 1 diabetes. Diabetes Res Clin Pract. 2011;91.
  7. England, et al. Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve. 2005;31.
  8. Dyck, et al. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain. 1985;108 ( Pt 4).
  9. Burke, et al. Sensory conduction of the sural nerve in polyneuropathy. J Neurol Neurosurg Psychiatry. 1974;37.